TORONTO , April 20, 2026 /CNW/ - Today, AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, announced the expansion of its partnership with BioLabs by becoming...
Three Dividend Kings with 50+ years of raises combine reliable income, solid growth, and analyst support, making them stand out in a shaky market.
IRVINE, Calif. , April 14, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) has teamed up with New York-based entrepreneur and television personality, Erin Lichy. Lichy is...
2 S&P 500 Stocks with Solid Fundamentals and 1 We Brush Off
Revolution Medicines stock rallies on impressive daraxonrasib Phase 3 results. Here’s why RVMD shares may sustain the momentum moving forward.
NORTH CHICAGO, Ill. , April 12, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that late-breaking results from the Phase 2 IMGN853-0420 trial will be presented in an oral session at the...
3 Market-Beating Stocks with Competitive Advantages
These three Dividend Aristocrats offer yields above 3% and a history of consistent dividend growth, making them strong choices to help stay ahead of inflation.
A strong dividend stock may not only pay a healthy distribution, but also be able to continue to grow its payouts thanks to steady, strong business.